{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T11:17:04Z","timestamp":1694603824877},"reference-count":19,"publisher":"Universa BV","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Orthop Belg"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:p>Collagenase clostridium histolyticum (CCH) is a pharmaceutical, non-surgical treatment option for Dupuytren Disease. However, recurrence is common, and predictors of treatment outcome of CCH treatment are largely unknown. In this retrospective study, we analysed the possible correlation between Abe\u2019s Dupuytren Diathesis Score (DDS) and recurrence after treatment with CCH. In a total of 74 patients, with an average follow-up of 5 years, we found an overall recurrence rate of 67% after 5y but no correlation with DDS. Sub-scale analysis indicated that the presence of knuckle pads was associated with a reduced recurrence risk. Patient satisfaction after CCH was high. Deriving from our data, there is no correlation between DDS and recurrence following CCH treatment. Therefore, at this moment, we do not advocate the use of the DDS when informing patients about recurrence rates after CCH treatment.\n\nLevel of evidence: IV: therapeutic cohort study.<\/jats:p>","DOI":"10.52628\/89.2.11781","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T13:20:59Z","timestamp":1694524859000},"page":"233-240","source":"Crossref","is-referenced-by-count":0,"title":["Long-term clinical outcome of collagenase clostridium histolyticum treatment is independent of Dupuytren Diathesis Score"],"prefix":"10.52628","volume":"89","author":[{"given":"Maarten","family":"VAN NUFFEL","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jantine","family":"POSTHUMA DE BOER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrien","family":"COOTJANS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"BORGERS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"DE SMET","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilse","family":"DEGREEF","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"27062","published-online":{"date-parts":[[2023,8]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Hansen KL, Werlinrud JC, Larsen S, Ipsen T, Lauritsen J. Difference in Success Treating Proximal Interphalangeal and Metacarpophalangeal Joints with Collagenase: Results of 208 Treatments. Plast Reconstr Surg Glob Open. 2017;5:e1275.","DOI":"10.1097\/gox.0000000000001275"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Hindocha S, Stanley JK, Watson S, Bayat A. Dupuytren\u2019s diathesis revisited: Evaluation of prognostic indicators for risk of disease recurrence. J Hand Surg Am. 2006;31(10):1626-34.","DOI":"10.1016\/j.jhsa.2006.09.006"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Hurst LC, Badalamente MA, Hentz VR, Hotchkiss RN, Kaplan FT, Meals RA, et al. Injectable collagenase clostridium histolyticum for Dupuytren\u2019s contracture. N Engl J Med. 2009;361:968-79.","DOI":"10.1056\/nejmoa0810866"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Peimer CA, Skodny P, Mackowiak JI. Collagenase clostridium histolyticum for dupuytren contracture: patterns of use and effectiveness in clinical practice. The Journal of hand surgery. 2013;38:2370-6.","DOI":"10.1016\/j.jhsa.2013.08.114"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Dolmans GH, De Bock GH, Werker PM. Dupuytren Diathesis and Genetic Risk. The Journal of Hand Surgery. 2012;37(10):2106-11.","DOI":"10.1016\/j.jhsa.2012.07.017"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Abe Y, Rokkaku T, Ofuchi S, Tokunaga S, Takahashi K, Moriya H. An objective method to evaluate the risk of recurrence and extension of Dupuytren\u2019s disease. J Hand Surg Br. 2004;29:427-30.","DOI":"10.1016\/j.jhsb.2004.06.004"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Cooper TB, Poonit K, Yao C, Jin Z, Zheng J, Yan H. The efficacies and limitations of fasciectomy and collagenase clostridium histolyticum in Dupuytren\u2019s contracture management: A meta-analysis. J Orthop Surg (Hong Kong). 2020;28:2309499020921747.","DOI":"10.1177\/2309499020921747"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Werlinrud JC, Hansen KL, Larsen S, Lauritsen J. Five-year results after collagenase treatment of Dupuytren disease. J Hand Surg Eur Vol. 2018;43:841-7.","DOI":"10.1177\/1753193418790157"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Hentz VR, Watt AJ, Desai SS, Curtin C. Advances in the Management of Dupuytren Disease: Collagenase. Hand Clinics. 2012;28:551-63.","DOI":"10.1016\/j.hcl.2012.08.003"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Skov ST, Bisgaard T, S\u00f8ndergaard P, Lange J. Injectable Collagenase Versus Percutaneous Needle Fasciotomy for Dupuytren Contracture in Proximal Interphalangeal Joints: A Randomized Controlled Trial. J Hand Surg Am. 2017;42:321-8.e3.","DOI":"10.1016\/j.jhsa.2017.03.003"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Gilpin D, Coleman S, Hall S, Houston A, Karrasch J, Jones N. Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren\u2019s disease. J Hand Surg Am. 2010;35:2027-38.e1.","DOI":"10.1016\/j.jhsa.2010.08.007"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Duquette S, Kuster R, Evans T, Wooden W, Munshi I, Cohen A, et al. Treatment of Dupuytren Contracture With Injectable Collagenase Within the Veterans Affairs System. JAMA Surg. 2017;152:204-5.","DOI":"10.1001\/jamasurg.2016.3605"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Nordenskj\u00f6ld J, Lauritzson A, \u00c5kesson A, Atroshi I. Collagenase injections for Dupuytren disease: 3-year treatment outcomes and predictors of recurrence in 89 hands. Acta Orthop. 2019;90:517-22.","DOI":"10.1080\/17453674.2019.1663472"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Sanjuan-Cervero R, Carrera-Hueso FJ, Vaquero-Perez M, Montaner-Alonso D. Recurrent Dupuytren\u2019s disease after fasciectomy and collagenase injection are histologically indistinguishable. J Hand Surg Eur Vol. 2020;45:508-12.","DOI":"10.1177\/1753193419900483"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"van Rijssen AL, Werker PMN. Percutaneous Needle Fasciotomy for Recurrent Dupuytren Disease. The Journal of Hand Surgery. 2012;37:1820-3.","DOI":"10.1016\/j.jhsa.2012.05.022"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Eberlin KR, Kobraei EM, Nyame TT, Bloom JM, Upton J, 3rd. Salvage palmar fasciectomy after initial treatment with collagenase clostridium histolyticum. Plast Reconstr Surg. 2015;135:1000e-6e.","DOI":"10.1097\/prs.0000000000001282"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Watt AJ, Curtin CM, Hentz VR. Collagenase injection as nonsurgical treatment of Dupuytren\u2019s disease: 8-year follow-up. J Hand Surg Am. 2010;35:534-9, 9.e1.","DOI":"10.1016\/j.jhsa.2010.01.003"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Tang JB, Giddins G. Why and how to report surgeons\u2019 levels of expertise. J Hand Surg Eur Vol. 2016;41:365-6.","DOI":"10.1177\/1753193416641590"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Peimer CA, Blazar P, Coleman S, Kaplan FTD, Smith T, Lindau T. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium Histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data. The Journal of Hand Surgery. 2015;40:1597-605.","DOI":"10.1016\/j.jhsa.2015.04.036"}],"container-title":["Acta Orthopaedica Belgica"],"original-title":[],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T13:21:03Z","timestamp":1694524863000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.actaorthopaedica.be\/archive\/volume-89\/issue-2\/original-studies\/long-term-clinical-outcome-of-collagenase-clostridium-histolyticum-treatment-is-independent-of-dupuy\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,8]]},"published-print":{"date-parts":[[2023,6,30]]}},"URL":"https:\/\/doi.org\/10.52628\/89.2.11781","relation":{},"ISSN":["0001-6462"],"issn-type":[{"value":"0001-6462","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]}}}